Health Trials

Botulinum Toxins, Type A

2

Review clinical trials related to Botulinum Toxins, Type A. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)

The purpose of this study is to assess the safety and efficacy of NT 201 compared with placebo in participants with moderate to severe platysma prominence. The study will be conducted in two periods: Main Period (MP) and Open label Extension Period (OLEX).

Participants needed: 300
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Merz Aesthetics GmbHUpdated: Jun 12, 2026Locations: 26
Eligibility criteria

Presence of four (medial and lateral, left and right) platysmal bands assessed a... [+1]

Hypersensitivity or a history of allergic reaction to botulinum toxin of any ser... [+6]

Read more
Status: Recruiting

Effect of Blood Flow by Botulinum Toxin Injection for Severe Peripheral Artery Occlusive Disease

The purpose of this study is to investigate the effect of subcutaneous injection of botulinum toxin A on wound healing caused by lower extremity ischemia.

Participants needed: 15
Trial details
Phase: Phase 4Age: 20+Biological sex: AllType: InterventionalSponsor: Yonsei UniversityUpdated: Mar 17, 2025Locations: 1
Eligibility criteria

Age ≥ 20 years old [+5]

Patients with diseases that can affect neuromuscular function, such as myastheni... [+11]

Read more